Inactivity of terbinafine in a rat model of pulmonary aspergillosis

No abstract is available for this paper.

• Publication year

  1990

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  1990-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF01967386PMID 2128278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of aerosol amphotericin B in rats

  1990cited by this paper
• An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis.

  1988cited by this paper
• A new bioassay for terbinafine

  1988cited by this paper
• Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis

  1988cited by this paper
• MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp

  1988cited by this paper
• Activity of terbinafine in experimental fungal infections of laboratory animals

  1987cited by this paper
• Antifungal activity of the allylamine derivative terbinafine in vitro

  1987cited by this paper
• In-vitro studies with SF 86-327, a new orally active allylamine derivative.

  1985cited by this paper
• Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes.

  1985cited by this paper
• Specific inhibition of fungal sterol biosynthesis by SF 86-327, a new allylamine antimycotic agent

  1985cited by this paper
• Synthesis and antifungal activity of (E)-N-(6,6-dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphtha lenemethanamine (SF 86-327) and related allylamine derivatives with enhanced oral activity.

  1984cited by this paper
• Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicans

  1984cited by this paper
• Aspergillosis complicating neoplastic disease.

  1973cited by this paper

• Diverse antifungal potency of terbinafine as a therapeutic agent against Exophiala dermatitidis in vitro

  2024cites this paper
• Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections

  2022cites this paper
• Inhalable microparticles containing terbinafine for management of pulmonary fungal infections: Spray drying process engineering using lactose vs. mannitol as excipients

  2020cites this paper
• Invasive Scedosporium spp. and Lomentospora prolificans Infections in Pediatric Patients: Analysis of 55 Cases from FungiScope® and the Literature.

  2019cites this paper
• Therapeutic Review: Terbinafine

  2012cites this paper
• Terbinafine: a pharmacological and clinical review

  2009cites this paper
• Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation

  2008cites this paper
• Use of terbinafine in rare and refractory mycoses.

  2008cites this paper
• Effects of Serum on In Vitro Susceptibility Testing of Echinocandins

  2007cites this paper
• Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats.

  2007cites this paper
• In Vitro Interactions of Approved and Novel Drugs against Paecilomyces spp

  2004influential citation
• Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis.

  2003cites this paper
• Avaliação de drogas antifúngicas no tratamento de camundongos BALB/c inoculados com o Lacazia loboi

  2003cites this paper
• Efficacy of Antifungal Therapy in a Nonneutropenic Murine Model of Zygomycosis

  2002cites this paper
• Use of Terbinafine in Mouse and Rat Models of Pneumocystis carinii Pneumonia

  2002cites this paper
• , C . and Outcome In Vivo Susceptibility to Amphotericin B In Vitro and Lack of Correlation between Inoculum Dependence with Itraconazole : Aspergillus flavus Susceptibility Testing of

  2001cites this paper
• Susceptibility Testing of Aspergillus flavus: Inoculum Dependence with Itraconazole and Lack of Correlation between Susceptibility to Amphotericin B In Vitro and Outcome In Vivo

  2001cites this paper
• Membrane and cell wall targets in Aspergillus fumigatus.

  2001cites this paper
• Fungal cell wall inhibitors: emphasis on clinical aspects.

  2000cites this paper
• Current management of onychomycosis. An overview.

  1997cites this paper
• Terbinafine in the treatment of non‐immunocompromised compassionate cases of bronchopulmonary aspergillosis

  1996cites this paper
• Influence of serum protein binding on theIn Vitro activity of anti-fungal agents

  1995cites this paper
• Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia.

  1994cites this paper
• Treatment and developmental therapeutics in aspergillosis. 2. Azoles and other antifungal drugs.

  1992cites this paper
• Interaction of terbinafine with human serum and serum proteins.

  1992cites this paper